This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Understand what makes a good financial plan and how it can guide your business decisions. Create a plan that drives your success.
23,277 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
A high profile roast goes viral and reveals more than punchlines. This article uses the michael mocks white writers m...
Rural living dreams collide with hard numbers as turnkey off-grid homes push into six figures and beyond. Investors a...
Retirees who claimed social security here’s at 62 may still see bigger monthly checks later, thanks to a do-over rule...
MercadoLibre dominates LATAM e-commerce and fintech, but the stock has pulled back from its peak. This guide explains...
A large required minimum distribution can push high earners into higher Medicare surcharge brackets. Here's how it wo...
Taiwan just enacted sweeping crypto legislation that brings licensing for virtual asset firms and new rules for stabl...
A quiet pivot from consumer devices to AI infrastructure has propelled this former smartphone maker into the spotligh...
A high-profile insider sale puts Credit Acceptance and its subprime finance niche in the spotlight. This piece breaks...
Zillow's latest forecast for 2026 hints at a shifting housing landscape. This guide breaks down what it means for mor...
When kate middleton meets babies during a Welsh engagement, the moment resonates beyond headlines. This article trans...
As yields rise and policy risks loom, the idea of bond vigilantes returning to the market is back in focus. Learn wha...